Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00279799 · ClinicalTrials.gov registry record · Phase 3
HIV Prevention for African American Teens
A Phase 3 study, sponsored by Emory University.
- Completed
- Registry status
- Phase 3
- Development phase
- 701
- Enrollment target
NCT00279799: Completed Phase 3 study, sponsored by Emory University.
NCT00279799 is a Phase 3 study that has completed, run by Emory University. The registered enrollment target is 701 participants, roughly in line with the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00279799, a Phase 3 study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 701 participants
- Enrollment target
Study Summary
AFIYA aims to reduce both the risk of Sexually Transmitted Infections (STIs) and HIV in young African American females through a culturally and gender appropriate intervention (group sessions) coupled with an individualized HIV Telephone Maintenance Intervention.
Interventions
- BEHAVIORAL Afiya HIV Prevention Intervention
- BEHAVIORAL Afiya HIV prevention intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 701 participants |
| Start Date | 2005-02 |
| Est. Completion | 2013-02 |
| Phase | Phase 3 |
What the finished NCT00279799 record still lists
NCT00279799 is an interventional study that assigns participants to a tested intervention. The registered 701 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target.
The record links to 0 conditions, and to 2 interventions - of which Afiya HIV Prevention Intervention is the first listed.
NCT00279799 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00279799 about?
NCT00279799 is a clinical study titled "HIV Prevention for African American Teens". AFIYA aims to reduce both the risk of Sexually Transmitted Infections (STIs) and HIV in young African American females through a culturally and gender appropriate intervention (group sessions) coupled with an individualized HIV Telephone Maintenance Intervention.
What is the current status of trial NCT00279799?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 701 participants. The study started on 2005-02. Estimated completion is 2013-02.
What interventions are being tested in trial NCT00279799?
The interventions under investigation include: Afiya HIV Prevention Intervention (BEHAVIORAL), Afiya HIV prevention intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00279799?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00279799's enrollment target sits among peer trials
701 506th of 2000 higher than 1,495 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06027996 · 702 participants · NA
Melodi Matrix™ in Breast Reconstruction
- NCT00900419 · 700 participants
Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
- NCT01804686 · 700 participants · Phase 3
A Long-term Extension Study of PCI-32765 (Ibrutinib)
- NCT02107989 · 700 participants
Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia